Facebook Linkedin Twitter
Inside Precision Medicine Guardant’s Shield Colorectal Cancer Blood Test Clears FDA Panel

Clinical chemistry test

Colon cancer. Cancer attacking cell. Colon disease concept
Molecular Dx

Guardant’s Shield Colorectal Cancer Blood Test Clears FDA Panel

0
A study from Karolinska Institutet in Sweden shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA. [Darryl Leja
News & Features

Urine-Based Prostate Cancer Test Promises to Reduce Unnecessary Biopsies

0
Unseen woman pricking their finger to test their blood sugar level
Molecular Dx

Personalized Diet Based on Genetic Profile More Effective at Reducing Blood Sugar than Standard Approaches

0
Theme diabetes.the man whose glucose was measured by going to the home of healthcare professionals. It uses the technology of an instrument for measuring the level of glucose in the blood
News & Features

Diabetes Care Is More Effective When Care Providers Focus on Patient Experience

0
AI and ovarian cancer
Molecular Dx

Urine-Based Ovarian Cancer Test Shows Promise

0
Elderly Man Using Nebulizer
Molecular Dx

Inhalable Nanosensors Detect Early Lung Cancer in Mice

Alice McCarthy
0
Illustration showing prostate cancer
Molecular Dx

University of Miami Researcher to Lead Effort to Develop Urine Test for Prostate Cancer

0
Elderly man with Parkinsons disease holds spoon in both hands.
News & Features

Parkinson’s Test Flags Early Disease

0
Ulcerative Colitis Pains
Molecular Dx

AGA Releases Guidelines on Use of Fecal and Blood Tests for Monitoring Ulcerative Colitis

0
Doctor examining pregnant woman with his hands on her stomach
Molecular Dx

Having Large Babies Linked to Later Diabetes Risk

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine